Profile data is unavailable for this security.
About the company
Notable Labs Ltd, formerly Vascular Biogenics Ltd, is an Israel-based clinical-stage biopharmaceutical company committed to developing next-generation, targeted medicines for difficult-to-treat medical conditions. The Company has created a pipeline of therapeutics that address cancer and immune-inflammatory diseases with the goal of significantly improving patient outcomes and overcoming the limitations of approved treatments. The Company's product candidates are built off of two platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels, and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications.
- Revenue in USD (TTM)313.00k
- Net income in USD-16.74m
- Incorporated2000
- Employees16.00
- LocationNotable Labs Ltd320 Hatch DriveFOSTER CITY 94404United StatesUSA
- Phone+1 (415) 851-2410
- Fax+972 8993-5001
- Websitehttps://notablelabs.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Theriva Biologics Inc | 0.00 | -22.27m | 3.50m | 21.00 | -- | 1.33 | -- | -- | -1.25 | -1.25 | 0.00 | 1.23 | 0.00 | -- | -- | 0.00 | -41.30 | -36.95 | -48.49 | -40.16 | -- | -- | -- | -- | -- | -- | 0.0056 | -- | -- | -- | 8.37 | -- | 95.91 | -- |
ENDRA Life Sciences Inc | 0.00 | -9.57m | 3.50m | 21.00 | -- | 0.0311 | -- | -- | -45.63 | -45.63 | 0.00 | 6.21 | 0.00 | -- | -- | 0.00 | -97.17 | -132.00 | -117.34 | -157.28 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 23.67 | -- | -19.46 | -- |
TNF Pharmaceuticals Inc | 0.00 | -7.07m | 3.56m | 9.00 | -- | 0.153 | -- | -- | -5.53 | -5.53 | 0.00 | 10.28 | 0.00 | -- | -- | 0.00 | -25.59 | -76.20 | -31.13 | -84.38 | -- | 7.64 | -- | -4,290.96 | -- | -- | 0.00 | -- | -- | -- | 49.15 | -- | -- | -- |
Hepion Pharmaceuticals Inc | 0.00 | -28.37m | 3.61m | 22.00 | -- | 1.93 | -- | -- | -6.49 | -6.49 | 0.00 | 0.6142 | 0.00 | -- | -- | 0.00 | -133.45 | -61.43 | -167.53 | -68.82 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -7.92 | -- | -- | -- |
Artelo Biosciences Inc | 0.00 | -10.44m | 3.62m | 5.00 | -- | 0.4953 | -- | -- | -3.33 | -3.33 | 0.00 | 2.26 | 0.00 | -- | -- | 0.00 | -82.83 | -- | -88.23 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 7.87 | -- | -- | -- |
Cell MedX Corp | 0.00 | -142.49k | 3.66m | 0.00 | -- | -- | -- | -- | -0.0021 | -0.0021 | 0.00 | -0.0028 | 0.00 | -- | -- | -- | -190.76 | -703.78 | -- | -- | -- | 84.03 | -- | -2,996.54 | -- | -4.35 | -- | -- | -100.00 | -- | 71.22 | -- | -- | -- |
Oncternal Therapeutics Inc | 1.85m | -35.97m | 3.69m | 27.00 | -- | 0.2342 | -- | 2.00 | -12.19 | -12.19 | 0.6254 | 5.32 | 0.0495 | -- | -- | 68,370.37 | -96.40 | -49.40 | -116.52 | -54.51 | -- | -- | -1,948.70 | -1,342.98 | -- | -- | 0.00 | -- | -47.32 | -- | 10.62 | -- | -- | -- |
Silexion Therapeutics Corp | 0.00 | -523.87k | 3.69m | 0.00 | -- | 0.5765 | -- | -- | -0.1403 | -0.1403 | 0.00 | 0.6559 | 0.00 | -- | -- | -- | -3.13 | -- | -3.77 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -54.96 | -- | -- | -- |
Enveric Biosciences Inc | 0.00 | -10.59m | 3.70m | 7.00 | -- | 0.6048 | -- | -- | -3.67 | -3.67 | 0.00 | 0.6862 | 0.00 | -- | -- | 0.00 | -133.67 | -104.94 | -206.10 | -156.88 | -- | -- | -- | -243.54 | -- | -- | 0.00 | -- | -- | -- | 7.14 | -- | -- | -- |
Bone Biologics Corp | 0.00 | -5.12m | 3.73m | 2.00 | -- | 0.805 | -- | -- | -10.26 | -10.26 | 0.00 | 2.21 | 0.00 | -- | -- | 0.00 | -94.66 | -98.31 | -119.03 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -502.76 | -- | -- | -- |
CTT Pharmaceutical Holdings Inc | 0.00 | -1.67m | 3.75m | 0.00 | -- | 2.02 | -- | -- | -0.0822 | -0.0822 | 0.00 | 0.0346 | 0.00 | -- | -- | -- | -317.28 | 13.49 | -448.83 | 304.48 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -3,454.52 | -- | -- | -- |
Notable Labs Ltd | 313.00k | -16.74m | 3.77m | 16.00 | -- | 0.5244 | -- | 12.04 | -2.47 | -2.47 | 0.046 | 0.7439 | 0.0176 | -- | -- | 19,562.50 | -93.89 | -52.02 | -120.26 | -62.09 | 37.70 | 60.19 | -5,346.97 | -3,636.93 | -- | -- | 0.0405 | -- | -52.89 | -11.93 | 65.13 | -- | -50.69 | -- |
Azitra Inc | 408.20k | -9.96m | 3.77m | 10.00 | -- | 0.2751 | -- | 9.24 | -12.12 | -12.12 | 0.1151 | 1.80 | 0.0595 | -- | 1.83 | 40,820.00 | -145.30 | -- | -194.72 | -- | -- | -- | -2,440.46 | -- | -- | -- | 0.0191 | -- | 141.55 | -- | 6.02 | -- | -- | -- |
Palisade Bio Inc | 0.00 | -14.17m | 3.87m | 9.00 | -- | 0.3177 | -- | -- | -20.07 | -20.07 | 0.00 | 10.30 | 0.00 | -- | -- | 0.00 | -90.97 | -132.36 | -109.07 | -165.45 | -- | -- | -- | -27,892.32 | -- | -972.73 | 0.0339 | -- | -- | -0.7814 | 13.74 | -- | 18.53 | -- |
Synaptogenix Inc | 0.00 | -3.45m | 3.90m | 5.00 | -- | 0.1982 | -- | -- | -3.89 | -3.89 | 0.00 | 14.99 | 0.00 | -- | -- | 0.00 | -5.54 | -40.33 | -6.89 | -43.36 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -142.17 | -- | -3.21 | -- |
Lixte Biotechnology Holdings Inc | 0.00 | -4.03m | 4.00m | 3.00 | -- | -- | -- | -- | -1.83 | -1.83 | 0.00 | 0.9986 | 0.00 | -- | -- | 0.00 | -139.98 | -104.18 | -163.33 | -111.05 | -- | -- | -- | -- | -- | -563.88 | 0.00 | -- | -- | -- | 19.41 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Squarepoint OPS LLCas of 31 Mar 2024 | 63.70k | 0.66% |
Geode Capital Management LLCas of 30 Jun 2024 | 29.62k | 0.31% |
Mariner LLCas of 31 Mar 2024 | 22.00k | 0.23% |
Virtu Americas LLCas of 30 Jun 2024 | 21.95k | 0.23% |
Oppenheimer & Co., Inc. (Wealth Management)as of 30 Jun 2024 | 20.00k | 0.21% |
Morgan Stanley & Co. LLCas of 31 Mar 2024 | 19.30k | 0.20% |
Two Sigma Securities LLCas of 31 Mar 2024 | 14.44k | 0.15% |
XTX Markets LLCas of 31 Mar 2024 | 10.19k | 0.11% |
Wells Fargo Clearing Services LLCas of 31 Mar 2024 | 5.00k | 0.05% |
UBS Securities LLCas of 31 Mar 2024 | 3.93k | 0.04% |